Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001758833 | SCV001997118 | uncertain significance | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genome Diagnostics Laboratory, |
RCV001847330 | SCV002105141 | uncertain significance | Hereditary spastic paraplegia | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002540424 | SCV003285262 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-09-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004536293 | SCV004113943 | uncertain significance | SETX-related disorder | 2022-12-13 | criteria provided, single submitter | clinical testing | The SETX c.2543T>G variant is predicted to result in the amino acid substitution p.Val848Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.010% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-135204442-A-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Neuberg Centre For Genomic Medicine, |
RCV003446904 | SCV004171875 | uncertain significance | Amyotrophic lateral sclerosis type 4 | criteria provided, single submitter | clinical testing |